Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma

Published:2022-12 Issue:4 Volume:68 Page:
ISSN:2724-5985
Container-title:Minerva Gastroenterology
language:
Short-container-title:Minerva Gastroenterol

Author:

NICOLOSI Aurora,GAIA Silvia,RISSO Alessandra,ROSSO Chiara,ROLLE Emanuela,ABATE Maria L.,OLIVERO Antonella,ARMANDI Angelo,RIBALDONE Davide G.,CARUCCI Patrizia,FAGOONEE Sharmila,PELLICANO Rinaldo,SARACCO Giorgio M.,BUGIANESI Elisabetta,CAVIGLIA Gian P.

Publisher

Edizioni Minerva Medica

Subject

Gastroenterology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R08Y2022N04A0378

Reference35 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Hepatocellular Carcinoma

3. Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy

4. Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients

5. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of glypican-3 expression in hepatocellular carcinoma using multisequence magnetic resonance imaging-based histology nomograms;Quantitative Imaging in Medicine and Surgery;2024-07

2. Usefulness of Fibrosis-4 Index for the stratification of the risk of hepatocellular carcinoma development in patients with chronic hepatitis B on long-term follow-up: a single center experience;Minerva Gastroenterology;2024-01

3. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging;Frontiers in Oncology;2023-09-29

4. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior;Oncotarget;2023-03-21